Cargando…
Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening
CONTEXT: Identification of potentially fatal cardiac conditions in otherwise healthy athletes presents a major challenge to the sports medicine community. The requirements for preparticipation screening vary among countries and even from state to state within the United States. The mandated use of a...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445149/ https://www.ncbi.nlm.nih.gov/pubmed/23015913 http://dx.doi.org/10.1177/1941738109350405 |
_version_ | 1782243777968078848 |
---|---|
author | Gupta, Sanjaya Baman, Timir Day, Sharlene M. |
author_facet | Gupta, Sanjaya Baman, Timir Day, Sharlene M. |
author_sort | Gupta, Sanjaya |
collection | PubMed |
description | CONTEXT: Identification of potentially fatal cardiac conditions in otherwise healthy athletes presents a major challenge to the sports medicine community. The requirements for preparticipation screening vary among countries and even from state to state within the United States. The mandated use of an electrocardiogram as a screening implement has provoked international controversy. EVIDENCE ACQUISITION: Part 1 of this review highlights the current guidelines and controversies surrounding cardiovascular screening, with a focus on the diagnostic challenges associated with identifying athletes with inheritable cardiomyopathies. Data sources were limited to peer-reviewed publications from 1984 to the present. RESULTS: Preparticipation screening should include at least a history and a physical examination for all athletes, whereas use of an electrocardiogram is still controversial. Diagnosis of inherited cardiomyopathies presents unique challenges, particularly in hypertrophic cardiomyopathy, where many features can mimic those found in the “athlete’s heart.” CONCLUSIONS: Recognizing cardiac conditions in athletes that can predispose them to sudden cardiac death or other adverse outcomes is of vital importance, as is the appropriate exclusion of these athletes from competition. Further studies are needed to determine the most efficient and cost-effective means of screening and to increase the sensitivity and specificity of diagnostic testing for inheritable cardiovascular diseases. |
format | Online Article Text |
id | pubmed-3445149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-34451492012-09-26 Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening Gupta, Sanjaya Baman, Timir Day, Sharlene M. Sports Health Primary Care CONTEXT: Identification of potentially fatal cardiac conditions in otherwise healthy athletes presents a major challenge to the sports medicine community. The requirements for preparticipation screening vary among countries and even from state to state within the United States. The mandated use of an electrocardiogram as a screening implement has provoked international controversy. EVIDENCE ACQUISITION: Part 1 of this review highlights the current guidelines and controversies surrounding cardiovascular screening, with a focus on the diagnostic challenges associated with identifying athletes with inheritable cardiomyopathies. Data sources were limited to peer-reviewed publications from 1984 to the present. RESULTS: Preparticipation screening should include at least a history and a physical examination for all athletes, whereas use of an electrocardiogram is still controversial. Diagnosis of inherited cardiomyopathies presents unique challenges, particularly in hypertrophic cardiomyopathy, where many features can mimic those found in the “athlete’s heart.” CONCLUSIONS: Recognizing cardiac conditions in athletes that can predispose them to sudden cardiac death or other adverse outcomes is of vital importance, as is the appropriate exclusion of these athletes from competition. Further studies are needed to determine the most efficient and cost-effective means of screening and to increase the sensitivity and specificity of diagnostic testing for inheritable cardiovascular diseases. SAGE Publications 2009-11 /pmc/articles/PMC3445149/ /pubmed/23015913 http://dx.doi.org/10.1177/1941738109350405 Text en © 2009 The Author(s) |
spellingShingle | Primary Care Gupta, Sanjaya Baman, Timir Day, Sharlene M. Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening |
title | Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening |
title_full | Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening |
title_fullStr | Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening |
title_full_unstemmed | Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening |
title_short | Cardiovascular Health, Part 1: Preparticipation Cardiovascular Screening |
title_sort | cardiovascular health, part 1: preparticipation cardiovascular screening |
topic | Primary Care |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445149/ https://www.ncbi.nlm.nih.gov/pubmed/23015913 http://dx.doi.org/10.1177/1941738109350405 |
work_keys_str_mv | AT guptasanjaya cardiovascularhealthpart1preparticipationcardiovascularscreening AT bamantimir cardiovascularhealthpart1preparticipationcardiovascularscreening AT daysharlenem cardiovascularhealthpart1preparticipationcardiovascularscreening |